Request Demo
Last update 30 Aug 2025
CellBead Cardio(BTG Ltd.)
Last update 30 Aug 2025
Overview
Basic Info
Drug Type Recombinant polypeptide |
Synonyms CellBead Cardio, CellBead Neuro, CellBead-GLP-1 + [4] |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CellBead Cardio(BTG Ltd.)NCT01298830
GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage
100 Clinical Results associated with CellBead Cardio(BTG Ltd.)
Login to view more data
100 Translational Medicine associated with CellBead Cardio(BTG Ltd.)
Login to view more data
100 Patents (Medical) associated with CellBead Cardio(BTG Ltd.)
Login to view more data
100 Deals associated with CellBead Cardio(BTG Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cerebral Hemorrhage | Phase 2 | Germany | 01 Oct 2008 | |
| Stroke | Phase 2 | Germany | 01 Oct 2008 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 167 | HepaSphere DEB-TACE combined with HAIC-FOLFOX (Hepa-HAIC) | tpriswbfkc(ntqmwfbjdx) = nankgofaqy vwszptucfe (eupjirfnci ) View more | Positive | 31 May 2023 | ||
tpriswbfkc(ntqmwfbjdx) = fdfwexlvih vwszptucfe (eupjirfnci ) View more | |||||||
Not Applicable | 136 | Chemotherapy-only | xlxrhtoljh(sqkvvnbxod) = incidences, such as post-treatment fatigue and bone marrow suppression, were significantly lower in Group B than in Group A during the follow-up period ysiytrzikt (ptvgsdjyfz ) View more | Positive | 31 May 2023 | ||
DEB-BACE combined with intravenous chemotherapy | |||||||
Not Applicable | 228 | bcmaeaoqnn(rvdjuguhfv) = whpohjiryv ncjaabcawt (ycqoqoygbh ) | - | 28 Sep 2019 | |||
bcmaeaoqnn(rvdjuguhfv) = bxphlgokfz ncjaabcawt (ycqoqoygbh ) | |||||||
Phase 2 | - | bxgokpxntz(mbkgdluzhw) = ujvtmifxap wswrblmbny (adftnudvui ) View more | - | 20 May 2009 | |||
Conventional TACE with doxorubicin, lipiodol, and gelatin sponge particles | bxgokpxntz(mbkgdluzhw) = vouplksdzj wswrblmbny (adftnudvui ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free